Seeking Participants for an IRB Approved Chronic Idiopathic Constipation (CIC) Clinical Trial

  • Pharmacy Job Market Webinar

    Are you considering applying to pharmacy school but are concerned about job prospects when you graduate? Join us on Wednesday, July 28th at 8 PM Eastern to hear from three PharmDs about their experiences and options outside of retail pharmacy.


New Member
Jul 19, 2021

I am the Patient Recruitment and Administrative Coordinator at the San Francisco Research Institute, a global Clinical Research institute that has been conducting clinical trials over the last 25 years. We are currently seeking participants for our IRB approved Clinical Trial for a new medication for Chronic Idiopathic Constipation (CIC). CIC is a common intestinal disorder that occurs when bowel movements become difficult or less frequent. It is estimated that chronic constipation affects between 2 and 27% of the population, and impacts quality of life. Although a variety of treatment options are available for chronic constipation, subjects have reported low satisfaction with current treatment alternatives in multiple published studies.

We are seeking participants with Chronic Constipation within the San Francisco Bay Area and other surrounding cities for our IRB approved research study. This clinical trial consists of at least 4 visits within the span of 8-10 weeks to our study clinic. All study-related care is at no cost, and insurance is not required. You could be eligible to receive a significant compensation of up to $400 once you have completed the study. For more information on our IRB approved research study, our Informed Consent Form for Participation will be attached to this post. You do have the right to discontinue in the research study after starting with no penalty. You will not lose medical care or any legal rights.

If you are interested in joining this research, or if you have any questions or concerns, please feel free to contact us at our 24 hour phone service at (415)-745-4340 or visit our website at San Francisco Research Institute. You can also contact me through email at [email protected]. We ask that you do not contact us through this thread or send us a private message. We're very much looking forward to hearing from you.

Kind Regards,
San Francisco Research Institute
2435 Ocean Avenue
San Francisco, CA 94127

Protocol No.: 280CLD
IRB Protocol #20212571


  • Informed Consent for Participation in Research (1)-converted.pdf
    235.7 KB · Views: 0
About the Ads

Your message may be considered spam for the following reasons:

  1. Your new thread title is very short, and likely is unhelpful.
  2. Your reply is very short and likely does not add anything to the thread.
  3. Your reply is very long and likely does not add anything to the thread.
  4. It is very likely that it does not need any further discussion and thus bumping it serves no purpose.
  5. Your message is mostly quotes or spoilers.
  6. Your reply has occurred very quickly after a previous reply and likely does not add anything to the thread.
  7. This thread is locked.